Clinical trial
Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No…
NCT00003357 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003357 |
|---|---|
| Title | Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease |
| Official title | Vaccination of High Risk Breast Cancer Patients Lacking Identifiable Disease With GM2-KLH Conjugate Plus the Immunological Adjuvant QS21 |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological |
| Interventions | GM2-KLH vaccine, QS21 |
| Enrollment | 9 |
| Start date | Jan 1, 1998 |
| Primary completion | Nov 1, 2001 |
| Completion | Nov 1, 2001 |
| First posted | Aug 16, 2004 |
| Last update posted | Dec 13, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: